Evidence map›Paper›PMID 21278447›Full record

ReviewJournal of molecular cell biology2011

Prevention of DNA re-replication in eukaryotic cells.

Lan N Truong, Xiaohua Wu

Abstract readReview
In one paragraph

Review in Journal of molecular cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. APC/C prevents a noncanonical order of cyclin/CDK activity to maintain CDK4/6 inhibitor-induced arrest.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Comprehensive Effects ofFrontiers in plant science · 2022
    Article
  15. Review
  16. Regulation of DNA Replication Licensing and Re-Replication by Cdt1.International journal of molecular sciences · 2021
    Review
  17. Cell Cycle Control: A System of Interlinking Oscillators.Methods in molecular biology (Clifton, N.J.) · 2021
    Review
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lan N TruongDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.
Xiaohua Wu

Funding

Role of the Mre11/Rad50/Nbs1 complex in DNA damage response pathwaysR01CA102361 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI WU, XIAOHUA · 2003 to 2012
$4.1M
S-phase checkpoint and rereplication in mammalian cellsR01GM080677 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI WU, XIAOHUA · 2010 to 2018
$2.9M
SUPPLEMENT TO INVESTIGATIVE HEMATOLOGYT32DK007022 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI SOLOMON, DANIEL RENEE · 1986 to 2009
$2.3M
NCI NIH HHS R01 CA102361NIDDK NIH HHS DK007022-30NIGMS NIH HHS R01 GM080677
6 · The paper itself

Abstract

DNA replication is a highly regulated process involving a number of licensing and replication factors that function in a carefully orchestrated manner to faithfully replicate DNA during every cell cycle. Loss of proper licensing control leads to deregulated DNA replication including DNA re-replication, which can cause genome instability and tumorigenesis. Eukaryotic organisms have established several conserved mechanisms to prevent DNA re-replication and to counteract its potentially harmful effects. These mechanisms include tightly controlled regulation of licensing factors and activation of cell cycle and DNA damage checkpoints. Deregulated licensing control and its associated compromised checkpoints have both been observed in tumor cells, indicating that proper functioning of these pathways is essential for maintaining genome stability. In this review, we discuss the regulatory mechanisms of licensing control, the deleterious consequences when both licensing and checkpoints are compromised, and present possible mechanisms to prevent re-replication in order to maintain genome stability.

Indexed as

AnimalsCell CycleCell Cycle ProteinsDNADNA DamageDNA ReplicationEukaryotic CellsGenes, cdcGenomic InstabilityHumansCell Cycle ProteinsDNA

Identifiers

PMID21278447
PMCPMC3030972

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.